RBCBioscience Corp.

RBCBioscience Corp. specializes in nucleic acid extraction systems and associated kits for molecular diagnostics. Their portfolio includes automated and manual devices for tasks like whole blood genotyping, viral load testing, and RNA/DNA extraction from formalin-fixed paraffin-embedded (FFPE) samples. Examples include automated extractors like the MagCore® HF16 Plus and EDA systems, as well as specialized kits for large-volume viral nucleic acid isolation and mRNA analysis. These products are designed to support workflows in clinical and research settings.

RBCBioscience Corp. is headquartered in Taiwan. The company’s location influences its regulatory compliance processes, particularly for markets like the European Union, where devices must meet specific standards and undergo individual authorisation.

RBCBioscience Corp.’s devices are listed in the EUDAMED registry, which is the European Union’s database for medical devices. Listing in EUDAMED indicates compliance with EU regulatory requirements, though individual device authorisation (e.g., CE marking) is required for market placement in the EU. This registry helps stakeholders verify the company’s presence in the European medical device landscape.

All of RBCBioscience Corp.’s devices fall under EU Class A, the lowest risk category for in vitro diagnostic (IVD) devices. This classification is based on their intended use and risk profile—typically involving minimal risk to patients, such as nucleic acid extraction kits or automated extractors for diagnostic workflows. Class A devices generally require conformity assessment procedures like self-certification or a notified body review, depending on the specific device type.

RBCBioscience Corp.’s automated systems, such as the MagCore® EDA and HF16 Plus, are designed for high-throughput nucleic acid extraction in clinical and research settings. These devices streamline workflows for tasks like whole blood genotyping, viral load testing (e.g., for infectious diseases), and RNA/DNA extraction from FFPE samples. The automation reduces manual handling errors and improves efficiency, making them suitable for laboratories processing large sample volumes, such as hospitals or diagnostic centers.